Clinical Trials · NCT03379974

Exercise Versus DDAVP in Patients With Mild Hemophilia A

CompletedPhase 4Desmopressin (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Nationwide Children's Hospital
Enrollment
32
Start date
Jul 2018
Locations
4 sites, United States
Primary endpoint
•Factor 8 level after exercise [ Time Frame: Baseline, 30 min post intervention #1, 30 min post intervention #2 and 90 minute post intervention #2
View Desmopressin compound reference